Ionis Pharmaceuticals (IONS) Intangibles (2010 - 2022)
Ionis Pharmaceuticals (IONS) posted quarterly Intangibles of $29.6 million for Q3 2022, down 1.44% year-over-year from $30.0 million in Q3 2021, and up 1.9% quarter-over-quarter from $29.1 million in Q2 2022.
Ionis Pharmaceuticals (IONS) Intangibles (2010 - 2022) Analysis & Trends
Ionis Pharmaceuticals' Intangibles history runs 13 years deep, the most recent figure standing at $29.6 million for Q3 2022.
- In Q3 2022, Intangibles fell 1.44% year-over-year to $29.6 million; the TTM figure through Sep 2022 stood at $29.6 million (down 1.44% YoY), while the FY2021 annual figure was $29.0 million, up 3.82% from the prior year.
- Intangibles for Q3 2022 stood at $29.6 million, up from $29.1 million in the prior quarter.
- The five-year high for Intangibles was $30.0 million in Q3 2021, with the low at $22.9 million in Q1 2018.
- The 5-year median for Intangibles is $27.7 million (2020), against an average of $27.1 million.
- The sharpest annual moves came in 2019 and 2022: Intangibles increased 12.31% in 2019, then retreated 1.44% in 2022.
- Ionis Pharmaceuticals' Intangibles stood at $24.0 million in 2018, then advanced by 6.83% to $25.7 million in 2019, then climbed by 8.81% to $27.9 million in 2020, then increased by 3.82% to $29.0 million in 2021, then gained by 2.07% to $29.6 million in 2022.
- Business Quant data shows IONS's Intangibles at $29.6 million in Q3 2022, $29.1 million in Q2 2022, and $29.3 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 29.61 Mn |
| Jun 30, 2022 | 29.05 Mn |
| Mar 31, 2022 | 29.30 Mn |
| Dec 31, 2021 | 29.01 Mn |
| Sep 30, 2021 | 30.04 Mn |
| Jun 30, 2021 | 29.37 Mn |
| Mar 31, 2021 | 28.80 Mn |
| Dec 31, 2020 | 27.94 Mn |
| Sep 30, 2020 | 28.27 Mn |
| Jun 30, 2020 | 27.70 Mn |
| Mar 31, 2020 | 26.75 Mn |
| Dec 31, 2019 | 25.67 Mn |
| Sep 30, 2019 | 26.99 Mn |
| Jun 30, 2019 | 26.06 Mn |
| Mar 31, 2019 | 25.22 Mn |
| Dec 31, 2018 | 24.03 Mn |
| Sep 30, 2018 | 24.03 Mn |
| Jun 30, 2018 | 23.45 Mn |
| Mar 31, 2018 | 22.91 Mn |
| Dec 31, 2017 | 22.00 Mn |